18 research outputs found
Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations
Chondroitin sulfate (CS) is recommended as a therapeutic intervention in the multimodal approach of osteoarthritis (OA) management. CS has been studied extensively to describe its pharmacology (pharmacokinetic, in vitro and in vivo effects) and its clinical efficacy. Various results have been reported depending on the system of evaluation (model, dosage and duration) and the source of CS (origin and quality). The purpose of this review was to gather most of the available information about CS and to discuss its potency in OA management
A Single Amino Acid In The beta 1 Chain Of HLA-DR Explains The Majority Of The HLA Association With Giant Cell Arteriti
Pathophysiology and treatment of rheumatic disease
The Functional PTPN22 Variant R620W Is Strongly Associated With Giant Cell Artetitis Predisposition
Pathophysiology and treatment of rheumatic disease
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Pathophysiology and treatment of rheumatic disease